SCHEMBL710848

SCHEMBL710848

Sc1ccc(I)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18151 0.72 — —
SCHEMBL198094 0.71 — —
SCHEMBL31243289 0.71 — —
SCHEMBL4390590 0.71 CCR1 (0.46) —
SCHEMBL10834459 0.71 — —
Iodide SCHEMBL10484569 0.69 NOS3 (0.46) —
Iodide SCHEMBL10484675 0.69 NOS3 (0.46) —
SCHEMBL12301380 0.67 — —
SCHEMBL10484568 0.67 NOS3 (0.44) —
SCHEMBL21573141 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112289937-B Quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-08-23 — — CN claimed
CN-112289937-A Quantum dot light-emitting diode and preparation method thereof TCL集团股份有限公司 2021-01-29 — — CN claimed
CN-112289937-B Quantum dot light-emitting diode and preparation method thereof TCL科技集团股份有限公司 2022-08-23 — — CN disclosed
US-11322750-B2 Surface modified platinum or platinum alloy catalyst for oxygen reduction reaction TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2022-05-03 — — US disclosed
CN-112289937-A Quantum dot light-emitting diode and preparation method thereof TCL集团股份有限公司 2021-01-29 — — CN disclosed
US-20200343562-A1 SURFACE MODIFIED PLATINUM OR PLATINUM ALLOY CATALYST FOR OXYGEN REDUCTION REACTION TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) 2020-10-29 — — US disclosed
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 — — US disclosed
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 — — US disclosed
US-8124610-B2 Sodium channel inhibitors ICAGEN INC. (US) 2012-02-28 — — US disclosed
EP-2173743-A2 SODIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2010-04-14 — — EP disclosed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 — — US disclosed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 — — US disclosed
US-20090023740-A1 SODIUM CHANNEL INHIBITORS ICAGEN (US) 2009-01-22 — — US disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 — — WO disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 — — WO disclosed
US-3969526-A Anthelmintic 5-heterocycliothio and oxy-2-carbalkoxyaminobenzimidazles SMITHKLINE CORPORATION (US) 1976-07-13 — — US disclosed
Send feedback